Application of mPEG-CS-cRGD/Bmi-1RNAi-PTX nanoparticles in suppression of laryngeal cancer by targeting cancer stem cells

References

• Ahmad K, Rabbani G, Baig MH, et al. (2018). Nanoparticle-based drugs: A potential armamentarium of effective anti-cancer therapies[J]. CDM 19:1–17.
   Google Scholar
• Ait Bachir Z, Huang YK, He MYe, et al. (2018). Effects of PEG surface density and chain length on the pharmacokinetics and biodistribution of methotrexate-loaded chitosan nanoparticles[J]. IJN 13:5657–71.
   Google Scholar
• Arndt K, Grinenko T, Mende N, et al. (2013). CD133 is a modifier of hematopoietic progenitor frequencies but is dispensable for the maintenance of mouse hematopoietic stem cells[J]. Proc Natl Acad Sci USA 110:5582–7.
   PubMed Web of Science ®Google Scholar
• Ayob AZ, Ramasamy TS. (2018). Cancer stem cells as key drivers of tumour progression[J]. J Biomed Sci 25:20.
   PubMed Web of Science ®Google Scholar
• Caforio M, Sorino C, Iacovelli S, et al. (2018). Recent advances in searching c-Myc transcriptional cofactors during tumorigenesis[J]. J Exp Clin Cancer Res 37:239.
   PubMed Web of Science ®Google Scholar
• Chen C, Xu ZH, Wang L. (2020). The effect of morusin on stemness phenotype of laryngeal cancer stem cell[J]. Sichuan Da Xue Xue Bao Yi Xue Ban 51:650–7.
   PubMedGoogle Scholar
• D’souza AA, Shegokar R. (2016). Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications[J]. Expert Opin Drug Deliv 13:1257–75.
   PubMed Web of Science ®Google Scholar
• El Deeb NM, Abdelzaher E. (2014). Stem cell markers OCT4 and nestin in laryngeal squamous cell carcinoma and their relation to survivin expression[J]. Pathol Res Pract 210:751–8.
   PubMed Web of Science ®Google Scholar
• Fang X, Wang X, Li G, et al. (2018). SS-mPEG chemical modification of recombinant phospholipase C for enhanced thermal stability and catalytic efficiency[J]. Int J Biol Macromol 111:1032–9.
   PubMed Web of Science ®Google Scholar
• Gajbhiye KR, Gajbhiye V, Siddiqui IA, et al. (2019). cRGD functionalised nanocarriers for targeted delivery of bioactives[J]. J Drug Target 27:111–24.
   PubMed Web of Science ®Google Scholar
• García-Aranda M, Pérez-Ruiz E, Redondo M. (2018). Bcl-2 inhibition to overcome resistance to chemo- and immunotherapy[J]. Int J Mol Sci 19:3950.
   PubMed Web of Science ®Google Scholar
• Ghofrani M, Shirmard LR, Dehghankelishadi P, et al. (2019). Development of octreotide-loaded chitosan and heparin nanoparticles: Evaluation of surface modification effect on physicochemical properties and macrophage uptake[J]. J Pharm Sci 108:3036–45.
   PubMed Web of Science ®Google Scholar
• Helmi O, Elshishiny F, Mamdouh W. (2021). Targeted doxorubicin delivery and release within breast cancer environment using PEGylated chitosan nanoparticles labeled with monoclonal antibodies[J]. Int J Biol Macromol 184:325–38.
   PubMed Web of Science ®Google Scholar
• Hua Q, Mi B, Huang G. (2018). The emerging co-regulatory role of long noncoding RNAs in epithelial-mesenchymal transition and the Warburg effect in aggressive tumors[J]. Crit Rev Oncol Hematol 126:112–20.
   PubMed Web of Science ®Google Scholar
• Huang H, Hao J, Pang K, et al. (2020). A biflavonoid-rich extract from Selaginella moellendorffii Hieron. induces apoptosis via STAT3 and Akt/NF-κB signalling pathways in laryngeal carcinoma[J]. J Cell Mol Med 24:11922–35.
   PubMed Web of Science ®Google Scholar
• Hyun H, Park MH, Jo G, et al. (2021). Injectable glycol chitosan hydrogel containing folic acid-functionalized cyclodextrin-paclitaxel complex for breast cancer therapy[J]. Nanomaterials (Basel) 11:317.
   PubMedGoogle Scholar
• Javid A, Ghani MJ, Shahzad S, Rezaei-Zarchi S. (2020). Antineoplastic drug-loaded polymer-modified magnetite nanoparticles: Comparative analysis of EPR-mediated drug delivery[J]. Cell Biol Int 44:2042–52.
   PubMed Web of Science ®Google Scholar
• Jia H-R, Jiang Y-W, Zhu Y-X, et al. (2017). Plasma membrane activatable polymeric nanotheranostics with self-enhanced light-triggered photosensitizer cellular influx for photodynamic cancer therapy[J]. J Control Release 255:231–41.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Liu S, Hou L, et al. (2020). The implication of LncRNA MALAT1 in promoting chemo-resistance of laryngeal squamous cell carcinoma cells[J]. J Clin Lab Anal 34:e23116.
   PubMed Web of Science ®Google Scholar
• Jin Y, Lv L, Ning S-X, et al. (2020). The anti-tumor activity and mechanisms of rLj-RGD3 on human laryngeal squamous carcinoma Hep2 cells[J]. ACAMC 19:2108–19.
   Google Scholar
• Lin Z-L, Ding J, Sun G-P, et al. (2020). Application of Paclitaxel-loaded EGFR peptide-conjugated magnetic polymeric liposomes for liver cancer therapy[J]. Curr Med Sci 40:145–54.
   PubMed Web of Science ®Google Scholar
• Liu J, Meng T, Yuan M, et al. (2016). MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell[J]. Int J Nanomedicine 11:6713–25.
   PubMed Web of Science ®Google Scholar
• Liu L, et al. (2015). Effects of targeted nano-delivery systems combined with hTERT-siRNA and Bmi-1-siRNA on MCF-7 cells[J]. Int J Clin Exp Pathol 8:6674–82.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhao Q, Ding G, et al. (2018). Incidence and mortality of laryngeal cancer in China, 2008-2012[J]. Chin J Cancer Res 30:299–306.
   PubMed Web of Science ®Google Scholar
• Najafzadeh B, Asadzadeh Z, Motafakker Azad R, et al. (2021). The oncogenic potential of NANOG: An important cancer induction mediator[J]. J Cell Physiol 236:2443–58.
   PubMed Web of Science ®Google Scholar
• Qiu H-o, Wang H, Che N, et al. (2016). Identification and characterization of CD133(pos) subpopulation cells from a human laryngeal cancer cell line[J]. Med Sci Monit 22:1146–51.
   PubMed Web of Science ®Google Scholar
• Shao F, Lv M, Zheng Y, et al. (2015). The anti-tumour activity of rLj-RGD4, an RGD toxin protein from Lampetra japonica, on human laryngeal squamous carcinoma Hep-2 cells in nude mice[J]. Biochimie 119:183–91.
   PubMed Web of Science ®Google Scholar
• Silva Galbiatti-Dias AL, et al. (2018). Relationship between CD44(high)/CD133(high)/CD117(high) cancer stem cells phenotype and Cetuximab and Paclitaxel treatment response in head and neck cancer cell lines[J]. Am J Cancer Res 8:1633–41.
   PubMed Web of Science ®Google Scholar
• Singh P, et al. (2021). Role of cancer stem cells in head-and-neck squamous cell carcinoma - A systematic review[J]. J Carcinog 20:12.
   PubMedGoogle Scholar
• Steinbichler TB, Dudás J, Skvortsov S, et al. (2018). Therapy resistance mediated by cancer stem cells[J]. Semin Cancer Biol 53:156–67.
   PubMed Web of Science ®Google Scholar
• Tian L, Tao ZZ, Ye HP, et al. (2018). Over-expression of MEOX2 promotes apoptosis through inhibiting the PI3K/Akt pathway in laryngeal cancer cells[J]. Neoplasma 65:745–52.
   PubMed Web of Science ®Google Scholar
• van Schaijik B, Davis PF, Wickremesekera AC, et al. (2018). Subcellular localisation of the stem cell markers OCT4, SOX2, NANOG, KLF4 and c-MYC in cancer: a review[J]. J Clin Pathol 71:88–91.
   PubMed Web of Science ®Google Scholar
• Walcher L, et al. (2020). Cancer stem cells-origins and biomarkers: Perspectives for targeted personalized therapies[J]. Front Immunol 11:1280.
   PubMed Web of Science ®Google Scholar
• Wang J, Fan J, Gao W, et al. (2020). LY6D as a chemoresistance marker gene and therapeutic target for laryngeal squamous cell carcinoma[J]. Stem Cells Dev 29:774–85.
   PubMed Web of Science ®Google Scholar
• Wang X, Li Y, Tang X, et al. (2020). Stenotrophomonas maltophilia outer membrane protein A induces epithelial cell apoptosis via mitochondrial pathways[J]. J Microbiol 58:868–77.
   PubMed Web of Science ®Google Scholar
• Wathoni N, Rusdin A, Febriani E, et al. (2019). Formulation and characterization of α-mangostin in chitosan nanoparticles coated by sodium alginate, sodium silicate, and polyethylene glycol[J]. J Pharm Bioallied Sci 11:S619–s627.
   PubMed Web of Science ®Google Scholar
• Wei X, He J, Wang J, et al. (2018). MPEG-CS/Bmi-1RNAi nanoparticles synthesis and its targeted inhibition effect on CD133(+) laryngeal stem cells[J]. J Nanosci Nanotechnol 18:1577–84.
   PubMed Web of Science ®Google Scholar
• Weiss LD, van den Driessche P, Lowengrub JS, et al. (2021). Effect of feedback regulation on stem cell fractions in tissues and tumors: Understanding chemoresistance in cancer[J]. J Theor Biol 509:110499.
   PubMed Web of Science ®Google Scholar
• Xin Y, Huang Q, Tang J-Q, et al. (2016). Nanoscale drug delivery for targeted chemotherapy[J]. Cancer Lett 379:24–31.
   PubMed Web of Science ®Google Scholar
• Yan M, Chen J, Jiang H, et al. (2020). Effective inhibition of cancer cells by recombinant adenovirus expressing EGFR-targeting artificial microRNA and reversed-caspase-3[J]. PLoS One 15:e0237098.
   PubMed Web of Science ®Google Scholar
• Yoshida GJ. (2018). Emerging roles of Myc in stem cell biology and novel tumor therapies[J]. J Exp Clin Cancer Res 37:173.
   PubMed Web of Science ®Google Scholar
• Yu D, Liu Y, Yang J, et al. (2015). Clinical implications of BMI-1 in cancer stem cells of laryngeal carcinoma[J]. Cell Biochem Biophys 71:261–9.
   PubMed Web of Science ®Google Scholar
• Zhang X, Guo W, Wang X, et al. (2016). Antitumor activity and inhibitory effects on cancer stem cell-like properties of Adeno-associated virus (AAV) -mediated Bmi-1 interference driven by Bmi-1 promoter for gastric cancer[J]. Oncotarget 7:22733–45.
   PubMedGoogle Scholar
• Zhou L, et al. (2007). CD133, one of the markers of cancer stem cells in Hep-2 cell line[J]. Laryngoscope 117:455–60.
   PubMed Web of Science ®Google Scholar
• Zhu X, Heng Y, Zhou L, et al. (2020). Survival prediction and treatment strategies for patients with advanced laryngeal carcinoma: a population-based study[J]. Int J Clin Oncol 25:1483–91.
   PubMed Web of Science ®Google Scholar